INTRODUCTION
It has been reported that Statolon, a product of the mould Penicillium stoloniferum, was effective in inhibiting Friend virus-induced leukaemia in mice if given before infection (Wheelock, I967) . It has also been reported that one injection of Statolon 3 days after infection can produce long term clinical remissions in DBA2 mice infected with Friend virus (Wheelock, Caroline & Moore, I969) .
The antiviral and interferon-inducing activity of Statolon, originally thought to be a polysaccharide, is now known to be due to double-stranded RNA found in virus-like particles present in the moulds (Banks et al. I968, Kleinschmidt et al. I968) . Some years ago, in co-operation with Professor Sir Ernst Chain, we undertook a study on the biological and chemical properties of double-stranded RNA obtained from such moulds. The first paper described the effect of these interferon inducers on acute virus infections (Planterose et al. I97o) . With the availability of highly purified double-stranded RNA it was also of interest to investigate the effect of this on Friend disease, an example cf a non-acute virus infection. This paper reports on experiments to determine the effect of highly purified double-stranded RNA on Friend disease with special reference to the relationship between response and time of treatment relative to infection.
Recent studies on the effect of the synthetic polynucleotide poly I:C on Friend disease (Larson et al. I969a) have shown that there is a complex relationship between the effect on Friend virus and the time of poly I: C administration. Although there is a profound difference in the biological activity of different synthetic polynucleotides (e.g. between poly I: C and poly A: U), it is believed that the biological actions of poly I: C and naturally produced double-stranded RNAs are similar (Nemes et al. I969) . The present results give in more detail the time of treatment after infection for antitumour effect.
Friend virus was obtained from Dr M. Salaman, Department of Cancer Research, London Hospital Medical School, in the form of infected female Balb/C mice. The virus was passaged using the plasma of infected mice. Blood was collected by cardiac puncture and a 20 solution was made in phosphate-buffered saline containing 20 units heparin/ml. The blood cells were removed by centrifugation at 2000 g for 20 rain. and the supernatant fluid passed through an HP/EK filter (Carlson-Ford, pore size 45o nm.) and stored in ampoules at -7o °. A standard stock of plasma virus was used in all experiments.
Mice. All experiments were carried out in male CD I mice of ~8 to 22 g., obtained from Charles Rivers, France.
Double-stranded RNA was produced at Beecham Research Laboratories from a penicillium culture which contained a large amount of double-stranded RNA. The doublestranded RNA, when highly purified, was free from protein and DNA and had a sedimentation coefficient of approximately I2S. It exhibited marked hyperchromicity and a melting profile when heated and was relatively resistant to bovine pancreatic ribonuclease (KochLight Laboratories).
Assay of infection in mice. The progress of the disease was determined by comparison 14 days after infection of the spleen weights of the treated group with those of the control group. The ratio of spleen weight to body weight was also determined for each mouse. The results were subjected to standard statistical analysis.
RESULTS

Effect of a single dose of double-stranded RNA on splenomegaly induced by Friend virus
Double-stranded RNA was injected intraperitoneally into CD I mice at ~oo #g./mouse at various times. The results show ( Table I ) that, depending on the time of administration relative to infection at day o, the effect could be enchancement, no effect, or inhibition of splenomegaly.
Enhancement of splenomegaly occurred when double-stranded RNA was injected from 5 days before, or up to 3 days after infection. The mechanism of enhancement of Friend virus-induced splenomegaly is probably related to the immunosuppressive activity of the double-stranded RNA, since it is known that immunosuppressive agents enhance splenomegaly. Thus immunosuppression by antilymphocyte serum of Rauscher virus produces a similar increase in splenomegaly (Hirsh & Murphy, ~968) . In separate experiments the immunosuppressive action of the double-stranded RNA used here has been demonstrated (to be published).
Significant inhibition of splenomegaly occurred if double-stranded RNA was injected from day 7 up to day 11 after infection. This regression was rapid, as shown in a subsequent experiment in which inhibition of splenomegaly occurred at day I4 when ~oo #g./mouse of double-stranded RNA were injected on day ~3 (Fig. i) . Fig. ~ also shows the time course of splenomegaly in untreated mice infected at day o, as determined by sampling groups of lo mice on the days shown. The inhibition of splenomegaly produced by dosing later in infection has been interpreted as being mediated by interferon (Gresser et al. I967) . On the other hand, a more specific antiviral or antitumour effect, or a stimulation of the immune response, may be involved.
Further groups of mice dosed at day ~o remained free of evidence of splenomegaly for several weeks, but by Io weeks after infection 70 ~ of these mice had significant splenomegaly. This induction of a latent state of the disease is similar to that of Statoloninduced remissons (Wheelock et al. I969 ) . No effect on splenomegaly occurred if mice were treated on day + 5 (Table ~) . This may reflect interplay of the immunosuppressive and antileukaemic action of double-stranded RNA, or a non-reactive state.
No effect was observed on the spleen size of uninfected mice following injection of doublestranded RNA. 
Effect of multiple dosing
Further groups of mice were inoculated intraperitoneally with double-stranded RNA at 50 #g./mouse on alternate days (Table 2 ) and the effect on splenomegaly at day 14 compared with that for the infected controls. As with single dose administrations, three patterns occurred: 0) enhancement of splenomegaly at day I4 for doses given before infection (days -7 to -I) or in the first week of infection (days + I to + 7); (2) reduction in spleen weight at I4 days for doses given in the 2nd week of infection (days +7 to + II); (3) no significant effect on splenomegaly at day I4 for doses given on days + I to -t-I I.
These results may be interpreted as in the single dose experiments.
Histological examination of spleens
Spleens of uninfected mice show a discrete arrangement of red and white pulp (Fig. za) . In Friend virus-infected spleens the normal architecture is disrupted by massive infiltration of sheets of'Friend cells' into the red pulp (Fig. zb) . Spleens from infected mice ultimately become necrotic and haemorrhagic (Fig. 3a) .
Histological examination of the spleens of mice in which reduction of splenomegaly has resulted from treatment with double-stranded RNA show a return to more normal spleen structure (Fig. 3b) . The period during which the infection was susceptible to inhibition by double-stranded RNA appeared to correspond with the phase of the disease when rapid proliferation of Friend cells was causing the spleens to increase in size. The effect therefore appeared to be on proliferating cells or tissue. So it is of interest to note the disappearance of the Friend cell in treated spleens. The remission induced following one injection of double-stranded RNA had not relapsed 6 weeks after treatment, suggesting that the reduction in spleen weight was more than a temporary reduction in the number of Friend cells.
The mechanism by which the reversal of splenomegaly is produced is uncertain. Doublestranded RNA is a potent inducer of serum interferon which could be acting as an antiviral agent on Friend virus multiplication. Interferon could also be acting on the Friend cells themselves in a similar manner to its antitumour action described by Gresser (FontaineBrouty-Boy6 et al. I969; Gresser & Bourali, 1969) . On the other hand, the antitumour action may not be related to the interferon-inducing ability of double-stranded RNA. Poly I: C is known to exert an antitumour action against a variety of tumours such as a reticulum cell sarcoma in mice and adenovirus I2 in newborn hamsters (Levy, Law & Rabson, I969; Bart & Kopf, I969; Larson, Clark & Hilleman, I969b) . Most probably the synthetic and naturally occurring double-stranded RNAs have a common mode of action. The rapidity of the regression of infected spleens would tend to rule out the involvement of antibodies and delayed hypersensitivity immune mechanisms in the response.
Certain aspects of work with poly I: C have been criticized in that the absence of endotoxin contamination had not been established when assaying biological and toxicological activity (Hilleman, I97o) . The activity against Friend disease of our material has been shown to be due to double-stranded RNA which is Schwartzman negative.
